Professional Documents
Culture Documents
Ek Ah YG EIA: Page 5 Out of 11 Pages
Ek Ah YG EIA: Page 5 Out of 11 Pages
IA
Mask hypoglycemic: Sweat, Nausea
Indoramin Antihypertensive
Urapidil Antihypertensive, Benign prostatic INTRINSIC SYMPATHOMIMETIC ACTIVITY
hyperplasia
Partial agonists effect: Pindolol (Visken), Acebutolol (Sectral),
Terazosin Indications for alpha 1 sympatholytics Labetalol (Trandate)
GE
Inhibition of alpha 1 adrenergic smooth Advantage: Rebound hypertension or upon
muscle withdrawal
High blood pressure, Benign prostatic
hyperplasia
MEMBRANE STABILIZING ACTIVITY
ADR: First dose phenomenon/SYNCOPE
Orthostatic hypotension Anesthetic effect: Pindolol, Acebutolol, Propranolol,
Metoprolol, Labetalol
Y
Adjusted dose: 1/3, 1/4
Administration: Bedtime Disadvantage: Ocular topical
Acebutolol Bethanidine
Esmolol Debrisoquin
Atenolol
Metoprolol DIRECT ACTING CHOLINOMIMETICS
Celiprolol Choline esters: Acetylcholine, Carbachol chloride,
Nebivolol Betanechol, Methacholine chloride
Re
acetylcholinesterase
Oxime derivatives: Pralidoxime
Physiologic antidote Long term administration: Atropine
NICOTINIC BLOCKERS
Ganglionic blockers Inhibit NN
Neuromuscular blockers Inhibit NM